Human Health
Flanders (Belgium) is a global hotspot for health, driving innovation in medical biotech, medtech and digital health. The region brings together biotech pioneers, CROs, CMOs, CDMOs, and clinical trial experts to advance breakthroughs in areas such as oncology, neurology, regenerative medicine, and infectious and autoimmune diseases.
As the cluster for health innovation, Biovia sits at the heart of this dynamic ecosystem, working closely with the Flemish government to connect industry, research institutions, and healthcare providers. Together, we accelerate innovation in personalized medicine, advanced therapies, ATMPs, digital health solutions, and cutting-edge medtech.
Belgium’s strong biopharma and medtech value chain—spanning fundamental research, (pre)clinical trials, and state-of-the-art production—further strengthens this position.
Members lead the way
The topics for our Strategic Initiatives are chosen by our members, identified through member-driven dialogues and working groups. Together, we prioritize globally significant topics, reflecting the inherently international landscape of health innovation and build roadmaps for the future of Flanders.
Our Strategic Initiatives support our health innovation ecosystem by providing:
A helicopter view
Providing a helicopter view of the focal topic, to keep our members informed of the latest developments, events and key stakeholders through newsletters & events.
Collaborative projects
Creating collaborative projects together with our members to create tangible output and outcomes (e.g. case studies, R&D and systems innovation).
A collective voice
Representing a collective voice for our members, engaging constructively with government and other decision-making bodies for actionable progress and problem solving.
Projects, Platforms & Initiatives
Biovia represents Flanders in the EU co-funded HealthChain project, which is working to boost the digital transformation of healthcare across European regions.
The HICEE project aims to boost innovations in Central and Eastern Europe (CEE), where start-ups receive only a third of the European average for VC investments. Biovia is partner in this EU-funded project.
Biovia is a proud partner of EU co-funded PRECISEU, a European initiative connecting innovation ecosystems to accelerate truly personalized healthcare. By transferring practices and solutions across regions, PRECISEU scales up deep-tech healthcare innovations, focusing on advanced therapy medicinal products and health data.
NoBoCap stands for Notified Body Increased Capacity. Biovia is founding partner of this European consortium, providing support to companies navigating the regulations around medical devices and in vitro diagnostics. The project is co-funded by the EU.
ALCOVE is a European Interreg France-Wallonia-Flanders initiative, bringing together 17 partners from France and Belgium to enhance early lung cancer detection and make screening more accessible.
STEP4NAMs boosts animal-free healthtech innovation by validating and promoting new testing methods, helping Europe reduce animal use and accelerate safer medtech and drug development.
Biovia supports at.las, a platform that connects and supports professionals involved in cell and gene therapies.
Biovia is a founding partner and member of the board of Flanders Vaccine. This platform aims to stimulate innovation in vaccine-related research & business as well as to catalyse public-private partnerships.
Biovia is member of EuropaBio’s Healthcare Biotechnology Council. Biovia is also actively involved within the SME platform connecting smaller companies acting across all biotechnology sectors to share experiences, identify challenges and propose policy recommendations.
Biovia is the official project partner of The European Hub for Advanced Development in Regenerative Medicine and Biomaterials (EHAB), which aims to accelerate the delivery of innovative health techniques and products to patients who need it.
Biovia is supporting the development of alternative methods to animal testing. The RE-place project and database aims to centralize the existing expertise on NAMs in Belgium in one database.
BBMRI.be is the Belgian hub of the European research infrastructure for biobanking and biomolecular resources, supporting health and life sciences research. Biovia actively collaborates through the Stakeholder Involvement Working Group and supports several initiatives.
Biovia is one of the founding partners of the EU-funded InnoMedCatalyst project. Launched in 2024, this ambitious European initiative is designed to enhance the regional innovation capacity in precision and personalized medicine, with a specific focus on 5P Medicine: predictive, preventive, personalized, participatory and precise.
Internationalization
Cross-border collaboration is key to innovation, which is why Biovia connects with other regions and cluster organizations across the world to improve health for all.
Are you a Biovia member interested in expanding your horizons? Find out more about our international missions and internationalization workshops.
Background & publications
More info?
For more information on medical biotech, medtech, digital health, or business partnerships in these fields, our Biovia Domain Leads are here to help. Connect with the right expert below to explore opportunities, collaborations, or guidance tailored to your needs.
Katrien Lorré
Domain Lead - Medical Biotech
Liz Renzaglia
Domain Lead - Medtech & Digital Health
Rita Prota
Business Partnerships & Programs Lead
Stay tuned about the latest updates in health innovation
Subscribe to our newsletter and receive regular updates.